[Successful results in the interferon therapy of autoimmune disease in NZB/W strain mice]. 1984

I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova

The experiment used 50 female NZB/W mice divided into 2 groups of 25 animals each. Beginning at the age of 3 weeks and up to 1 year the animals of the experimental group were given once in 2 weeks 104 U/injection of mouse interferon intraperitoneally; the animals of the control group received physiological saline according to the same schedule. At the age of 3 months and subsequently at 6-week intervals up to 1 year mice of the two groups were examined for blood serum antibodies to native DNA and double-stranded RNA. The presence of p30 antigen of mouse leukemia virus in the spleen and blood serum was determined by the competitive radioimmunoassay in mice of both groups at the age of 3 months but not later because immune complexes with virus-specific antibodies appeared to be formed. The difference in the average longevity of the animals between the experimental (425 +/- 25.6 days) and control (315 +/- 15.1 days) groups is statistically highly significant. At the age of 3 months mice of the experimental group had significantly lower mean tires of antibody to DNA than in the control group (12.3 +/- 8.1 and 56.1 +/- 9.7, respectively), subsequently no significant differences in the titres were observed. Similar data were obtained with regard to antibodies to double-stranded RNA in the animals under 6 months of age. Morphological signs of development of lupus-nephritis in control mice appeared in histological studies earlier and were more marked than in the treated mice. It is concluded that the autoimmune disease in NZB/W mice was successfully treated with interferon.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008814 Mice, Inbred NZB An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS. Mice, NZB,Mouse, Inbred NZB,Mouse, NZB,Inbred NZB Mice,Inbred NZB Mouse,NZB Mice,NZB Mice, Inbred,NZB Mouse,NZB Mouse, Inbred
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012330 RNA, Double-Stranded RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. Double-Stranded RNA,Double Stranded RNA,RNA, Double Stranded

Related Publications

I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
April 1982, Fysiatricky a reumatologicky vestnik,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
September 1978, Infection and immunity,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
May 1980, Clinical and experimental immunology,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
December 1990, Cellular immunology,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
February 1991, The Journal of rheumatology,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
January 1987, Progress in clinical and biological research,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
January 1974, Series haematologica (1968),
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
October 2000, Scandinavian journal of immunology,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
February 1995, Immunopharmacology and immunotoxicology,
I F Barinskiĭ, and Z S Alekberova, and V A Savinov, and V A Nasonova
June 1998, Clinical and experimental immunology,
Copied contents to your clipboard!